Published online Dec 7, 2014. doi: 10.3748/wjg.v20.i45.17120
Revised: April 29, 2014
Accepted: July 24, 2014
Published online: December 7, 2014
Processing time: 287 Days and 1.3 Hours
AIM: To investigate differences of clinical characteristics and disease courses between familial and sporadic inflammatory bowel disease (IBD) patients.
METHODS: We obtained clinical data on Crohn’s disease (CD) (n = 691) and ulcerative colitis (n = 1113) from a tertiary referral medical center between 2005 and 2012. Seventeen patients (2.5%) with CD and 27 patients (2.4%) with ulcerative colitis (UC) were identified as having a familial history of IBD, including the first and second degree relatives. For each control case, three times the number of age-, sex-, and diagnosis year-matched CD and UC patients, without a family history of IBD, were randomly selected in this case control study.
RESULTS: There were no significant differences in age or main symptom at diagnosis, extraintestinal manifestation, location/extent, behavior of disease activity, number of hospitalizations, number of operations, operation type, number of relapses, or oral medical treatment between familial and sporadic CD and UC patients. Median (min-max) follow-up periods after diagnosis of familial CD and sporadic CD patients were 84 (24-312) and 36 (8-240) mo, respectively (P = 0.008). Familial CD patients more frequently used anti-tumor necrosis factor (TNF) antibodies compared to sporadic CD patients (17.6% vs 0%, P = 0.014).
CONCLUSION: In conclusion, a family history of IBD does not seem to be an important predictive factor affecting clinical characteristics or disease course even if there is a more frequent use of anti-TNF antibodies in familial CD patients compared to sporadic CD patients.
Core tip: We investigated differences of clinical characteristics and disease courses between familial and sporadic inflammatory bowel disease (IBD) patients. Despite several other studies of IBD, there is still insufficient knowledge regarding the clinical characteristics in familial IBD. We report that a family history of IBD does not seem to be an important predictive factor affecting clinical characteristics or disease course. Not only genetic background but also environmental factors might affect the disease course of IBD.